Purpose: Radicular pain is a frequently observed symptom of lumbar disk herniation or lumbar spinal canal stenosis. Achieving radicular pain relief is difficult. This type of pain may progress to chronic neuropathic pain. Calcitonin (elcatonin [eCT]) has been used mainly for hypercalcemia and pain associated with osteoporosis. The purpose of this study was to investigate analgesic effects of repeated eCT administration on radicular pain in male rats and changes in mRNAexpression levels of voltage-dependent sodium channels in the dorsal root ganglion (DRG). Methods: Seventy male Sprague-Dawley rats were used. A right L5 hemilaminectomy and an L5-L6 partial facetectomy were performed to expose the right L5 nerve root. Under a microscope, the right L5 spinal nerve root was tightly ligated extradurally with 8-0 nylon suture proximally to the DRG to cause radicular pain in rats. Mechanical hyperalgesia, thermal hyperalgesia, and analgesic effects of eCT were compared among rats with radicular pain that received eCT, those that received the vehicle, and sham rats that received the vehicle. Real-time reverse-transcription PCR was performed to measure mRNA-expression levels of tetrodotoxin-sensitive (Na V 1.3 and Na V 1.6) and tetrodotoxin-resistant (Na V 1.8 and Na V 1.9) sodium channels in the DRG. Results: Mechanical and thermal hyperalgesic reactions occurring in rats with radicular pain significantly improved on days 5 and 9 of eCT administration, respectively. In rats with radicular pain, mRNA-expression levels of Na V 1.3, Na V 1.8, and Na V 1.9 increased. After repeated eCT administration, mRNA-expression levels of these sodium channels in rats with radicular pain improved to the same levels as in sham rats.
Introduction
Radicular pain is a frequently observed symptom of lumbar disk herniation or lumbar spinal canal stenosis. It manifests as spontaneous pain and hyperalgesia generally located at the gluteal region, thigh, leg, and foot, and is believed to be caused by a series of changes in the sensory processing system, functional reorganization of sensory transmission, and development of neural plasticity in the peripheral and central nervous systems.
Radicular pain results from an injury at a site proximal to the dorsal root ganglion (DRG). To investigate pathophysiological changes involved in neuropathic pain, several
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Terashima et al types of animal models, such as chronic constriction injury (CCI), and spinal nerve ligation have been developed. 1, 2 The first reported animal model of radicular pain involved nerve-root ligation proximal to the DRG. 3 This model was later modified, 4 and it is characterized by long-lasting mechanical allodynia and thermal hyperalgesia, which mimic clinical symptoms of lumbar radicular pain that is observed in patients with lumbar spinal canal stenosis or lumbar disk herniation. We have previously reported studies using rat models of radicular pain in which injury to the nerve root increased the excitability and sodium-current amplitude of DRG. 4 We presume that radicular pain is caused by changes in sodium-channel expression and current properties.
Voltage-gated sodium channels are key transmitters in cellular excitability and are essential for pain transmission. 5 There are nine distinct voltage-gated sodium channel α-subunits: Na V 1.1-1.9. Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.4, Na V 1.6, and Na V 1.7 are sensitive to tetrodotoxin (TTX), whereas Na V 1.5, Na V 1.8, and Na V 1.9 are resistant to TTX. Several isoforms, except Na V 1.4 and Na V 1.5, are expressed in the DRG. 6 Na V 1.1, Na V 1.6, Na V 1.7, Na V 1.8, and Na V 1.9 are expressed in the adult DRG. 7 The expression of Na V 1.3 in the adult DRG contributes to abnormal sodium current, which has been implicated in various neuropathic pain disorders. 8 We focused on changes in the TTX-sensitive (Na V 1.3 and Na V 1.6) and the TTX-resistant (Na V 1.8 and Na V 1.9) sodium channels in this study.
In the clinical setting, NSAIDs are commonly used to treat radicular pain; however, these have a poor analgesic effect in cases of chronic pain (long disease durations) or severe neural disorders. Furthermore, the use of NSAIDs is often limited by the onset of adverse effects, such as gastrointestinal disorders, which are frequently observed with their long-term administration. It is often difficult to achieve radicular pain relief, and in some cases it may progress to chronic neuropathic pain.
Calcitonin is a polypeptide comprising 32 amino acids that is secreted into the blood from parafollicular cells (C cells) of the thyroid gland. It plays an important role in the regulation of bone metabolism as a hormone that suppresses bone resorption. Formulated eel calcitonin (elcatonin [eCT] ) and salmon calcitonin have been used mainly to treat hypercalcemia and pain associated with osteoporosis. [9] [10] [11] [12] eCT is more effective than NSAIDs in alleviating acute lumbar pain in the open-label randomized controlled trial. 13 Calcitonin has also been used for pain associated with diabetic neuropathy and complex regional pain syndrome in a clinical setting. 14, 15 Furthermore, studies have reported on the efficacy of calcitonin in pain reduction without relevant side effects. 10, 13 There are no experimental and clinical studies about the effects of calcitonin on radicular pain. The analgesic effects of calcitonin have been confirmed in diseases other than osteoporosis; however, these analgesic effects may be mediated by a different mechanism from that underlying its action as an inhibitor of bone resorption. Calcitonin induces a slow outward current associated with a decrease in sodium conductance causing membrane hyperpolarization in identified neurons of aplysia. 16 We expected calcitonin might have some effects on voltage-dependent sodium channels in the DRG. As such, the purpose of this study was to investigate the analgesic effects of repeated calcitonin administration on radicular pain in rats and to evaluate changes in mRNA-expression levels of voltage-dependent sodium channels in the DRG.
Methods
Experimental animals
A total of 70 male Sprague-Dawley rats weighing 150-170 g were used. All experimental procedures were approved by the Animal Care and Use Committee of the Sapporo Medical University School of Medicine, Sapporo, Japan. All efforts were made to minimize the animals' suffering and the number of animals used, and the experiments followed the ethical guidelines of the International Association for the Study of Pain. 17 The method used to generate lumbar radicular pain in rats is briefly described. 4, 18, 19 After rats had been anesthetized with inhalation of isoflurane, they were placed in the prone position. An incision was made posteromedially from L4 to S1 to expose the right L5-L6 facet joint. A right L5 hemilaminectomy and an L5-L6 partial facetectomy were performed to expose the right L5 spinal nerve root. Under a microscope, the right L5 spinal nerve root was tightly ligated extradurally with 8-0 nylon suture proximal to the DRG. Subcutaneous tissue and skin were then closed with 4-0 nylon sutures. In sham rats, L5-L6 intervertebral joints were exposed without constricting the spinal nerve root.
Calcitonin administration
eCT (20 U/kg; Asahi Kasei Pharma, Tokyo, Japan), a synthetic derivative of eel calcitonin, or the vehicle, was subcutaneously injected in the neck of rats with radicular pain five times per week for 3 weeks, starting on postoperative day 11. During the same period, sham rats were administered the vehicle. 
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Behavioral tests
For this experiment, 27 rats were divided into three groups: 10 rats with radicular pain that received eCT (RP + eCT group), 10 rats with radicular pain that received the vehicle (RP + vehicle group), and 7 sham rats that received the vehicle (sham + vehicle group). Mechanical hypersensitivity and thermal hyperalgesia were compared between the three groups to investigate the analgesic effects of eCT.
Mechanical hyperalgesia
Rats were placed on a wire-mesh floor inside a Plexiglas chamber (IITC Life Science, Los Angeles, CA, USA) measuring 18×25×18 cm. They were acclimatized to the environment for at least 20 minutes before the test. Mechanical stimuli were applied to the middle area between the footpads on the plantar surface of the right and left hind paws using a 3.8 g von Frey filament (Semmes-Weinstein; North Coast Medical, San Jose, CA, USA). This was repeated thrice at intervals of at least 10 minutes. Differences in the number of hind-paw escape responses between the affected and intact sides were the index for mechanical hyperalgesia, as in previous reports. 4, [18] [19] [20] This behavioral evaluation was conducted on the day before surgery and on postoperative days 4, 7, 10, 13, 15, 19, 22, 26, 29, 33, 36, and 40.
Thermal hyperalgesia
Rats were placed inside a Plexiglas chamber on a glass platform and allowed to acclimatize for at least 20 minutes before the test. A thermal stimulus was applied with a radiant heat source (Tail Flick Analgesia Meter; IITC Life Science) on the center of the hind paw, and the length of time (in seconds) of the hind paw's fleeing reaction was measured. This was alternately conducted on each foot five times at 5-minute intervals. The mean of differences between the affected and intact sides for the second to fifth stimulations was the index of thermal hyperalgesia and defined as the differential score. 4, [18] [19] [20] This procedure was performed after evaluating mechanical hyperalgesia.
mRNA-expression levels of voltagedependent sodium channels in DRG
To measure mRNA-expression levels of voltage-dependent sodium channels in the DRG, 43 rats were divided into three groups: 14 rats with radicular pain that received eCT (RP + eCT group), 14 rats with radicular pain that received the vehicle (RP + vehicle group), and 15 sham rats that received the vehicle (sham + vehicle group). On the day after eCT or vehicle administration, for 3 weeks (30 days postsurgery), rats were anesthetized with ether. After verifying that they were in deep anesthesia, the right L5 DRG was harvested.
Real-time reverse-transcription (RT) PCR was performed to measure mRNA-expression levels of TTX-sensitive (Na V 1.3, Na V 1.6) and TTX-resistant (Na V 1.8, Na V 1.9) sodium channels in the DRG. 21 The right L5 DRG was immersed in 0.5 mL RNAlater (Ambison, Austin, TX, USA) and stored at -80°C. RNA was extracted in a single step using Trizol (Thermo Fisher Scientific, Waltham, MA, USA) and chloroform. After centrifugation at 15,000 rpm for 15 minutes, the RNA-containing aqueous phase was precipitated in isopropanol. The RNA pellet was then washed once in 75% ethanol and resuspended in 100 µL RNase-free water. Total RNA from each sample was extracted using RNeasy minicolumns with DNase I (Qiagen NV, Venlo, the Netherlands) to reduce the contamination of genomic DNA prior to RT-PCR.
The primer and probe for Na V 1.3 were designed according to the TaqMan protocol, and those for Na V 1.8 and Na V 1.9 were designed following the method by Sleeper et al. 22 The software Primer Express (Thermo Fisher Scientific) was used, and the specificity was verified using BLAST. Commercial sets (Rn00570506_m1, TaqMan gene-expression assay; Thermo Fisher Scientific) for Na V 1.6 and rodent GAPDH control reagents (VIC Probe, 4308313; Thermo Fisher Scientific) were used. With GADPH as the endogenous control, mRNAexpression levels of sodium channels were normalized to those of GAPDH and then compared among the three groups.
Target genes were amplified using specific primers for Na V 1.3 (forward 5′-CCAATAACACGGGCATCGA-3′, reverse 5′-CACCCCGCTGGTGGTT-3′; probe 5′-FAM-ATAAGCAAAGAGCTTAACTACCTT-3′ [TaqMan MGB]), Na V 1.8 (forward 5′-TGGTCAACTGCGTGTGCAT-3′, reverse 5′-AATCAGAGCCTCGAAGGTGTAAA-3′; probe 5′ -FAM-CCGAACTGATCTTCCAGAGA-AAGTCGAGTACGT-TAMRA-3′), and Na V 1.9 (forward 5′-TGCCCTACCCACCTCACAAC-3′, reverse 5′-CCGGGCTAGTGAGCTGCTT-3′; probe 5′-FAM-TICAGGCCGGTGACCTCCCTCC-TAMRA-3′). Primers for GAPDH and the others were used at final concentrations of 100 and 900 nM, respectively, whereas probes were used at final concentrations of 200 and 250 nM, respectively. Realtime RT-PCR was performed using TaqMan one-step RT-PCR reaction-mix reagent. Amplification was performed in a final volume of 50 µL under conditions of 30 minutes at 48°C, 10 minutes at 95°C, and then 40 cycles of 95°C for 15 seconds each, followed by 60°C for 1 minute. To determine transcript levels, relative standard-curve methods were constructed using a serial dilution of RNA from each tissue sample. 
Statistical analyses
All numerical data are expressed as mean ± SEM. Behavioral test data were analyzed with two-way repeated-measure ANOVA. Among-and between-group comparisons were done using Dunnett's test and unpaired Student's t-test, respectively. P<0.05 was considered statistically significant.
Results
Evaluation of behavioral tests
The time courses of withdrawal frequencies in the RP + eCT, RP + vehicle, and sham + vehicle groups in response to mechanical stimuli using 3.8 g von Frey filament are shown in Figure 1A . Rats with radicular pain exhibited a significantly higher level of mechanical hyperalgesia from postoperative day 4 and thereafter than the sham rats (P<0.05). Furthermore, mechanical hyperalgesia was gradually relieved by eCT administration, and a significant improvement was observed in the RP + eCT group 5 days after starting eCT administration compared with the RP + vehicle group (P<0.05). Although hyperalgesia improved during the repeated eCT administration, it recurred 7 days after completing the treatment.
The differential score for noxious thermal stimuli was significantly higher in rats with radicular pain than in sham rats at postoperative day 4 and thereafter (P<0.05, Figure 1B) . Furthermore, although hyperalgesia to heat stimulation improved significantly on day 9 after starting eCT administration, thermal hyperalgesia recurred 7 days after completing the treatment.
Change in mRNA-expression levels of voltage-dependent sodium channels in DRG The right L5 DRG was harvested on the day following eCT administration, or vehicle administration for 3 weeks (30 days postsurgery). Sodium-channel mRNA-expression levels were normalized to those of GAPDH and then compared among the RP + eCT, RP + vehicle, and sham + vehicle groups using relative values to the mean value of the sham group.
mRNA-expression levels of Na V 1.3 for the sham + vehicle and RP + vehicle groups were 0.82±0.04 and 1.19±0.09, respectively; therefore, the expression increased significantly in the latter group (P<0.05). In the RP + eCT group, the expression level was 0.98±0.04, indicating that expression levels of Na V 1.3 improved to the same level as those of the sham group (Figure 2A) . However, no significant differences were observed in expression levels of Na V 1.6 among the sham + vehicle (0.62±0.03), RP + vehicle (0.71±0.06), or RP + eCT (0.59±0.04, Figure 2B ) groups.
In contrast, mRNA-expression levels of Na V 1.8 and Na V 1.9 were 0.92±0.07 and 0.92±0.08 in the sham + vehicle group and 1.37±0.10 and 1.26±0.10 in the RP + vehicle group, respectively; therefore, levels increased significantly in the latter group (P<0.05). Furthermore, levels were 0.94±0.05 and 0.99±0.06 in the RP + eCT group, respectively, indicating that mRNA-expression levels of Na V 1.8 and Na V 1.9 improved to the same level as those in the sham group ( Figure 2C and D) .
Discussion
Mechanical and thermal hyperalgesic reactions occurring in rats with radicular pain had improved significantly by days 5 and 9 of calcitonin administration, respectively, demonstrating that repeated systemic administration of calcitonin was effective in reducing radicular pain, mechanical hyperalgesia (allodynia), and thermal hyperalgesia. Although few preclinical experiments have demonstrated the analgesic effects of calcitonin, the efficacy of calcitonin in a model of acute pain in rats has been reported. 25 Prior to the injection of formalin into the footpads of rats, these were treated with repeated subcutaneous injections of calcitonin (4 U/kg/day) for 7 days. As a result, the intervention suppressed hyperalgesia in rats with acute pain. Aoki et al 26 reported that calcitonin (20 U/kg/ day) almost completely reversed the effects of both cold and mechanical allodynia induced by oxaliplatin and paclitaxel. Ovariectomized rats with hyperalgesia improved after subcutaneous calcitonin administration (20 U/kg/day) for 3 weeks in a postmenopausal osteoporosis and chronic pain model. 27 Although calcitonin disappears within 2 hours of injection into human and rat plasma, subsequent injection of calcitonin gradually enhances antihyperalgesic effects. 28 These effects are maintained for several days after cessation of calcitonin administration. 21, 26 Ito et al 21 found dose-dependent effects of eCT (1.5, 15, and 30 U/kg/day) on both mechanical and thermal hyperalgesia in CCI rats. The present study results demonstrated that subcutaneous administration of eCT (20 IU/kg/day, five times a week) for 3 weeks produced full relief of radicular pain in rats. Hyperalgesic reactions recurred 7 days after the completion of calcitonin administration. This finding suggests that calcitonin inhibits pain via direct antinociception on damaged nerves. Further study is needed to investigate the smallest single-dose quantity of eCT and the ideal number of administration times for suppressing radicular pain in rats. Calcitonin injected systemically binds to calcitonin receptors at blood-brain barrier-free regions, 
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Calcitonin for radicular pain On day 5 after starting administration, hyperalgesia improved significantly in these rats compared with those that received the vehicle. However, they exhibited hyperalgesic reactions again 7 days after completing eCT administration. (B) Thermal hyperalgesia was evaluated using the differential score. This score for each rat was the thermal withdrawal latency of the injured side subtracted from the thermal withdrawal latency of the uninjured side. Withdrawal latency was defined as the time from the onset of radiant heat to the withdrawal of the tested foot. Mean withdrawal latency was calculated from the last four measurements. The differential score was significantly higher in the RP + vehicle group than in the sham + vehicle group from day 4 and thereafter. Hyperalgesia to a thermal stimulus had improved significantly 9 days after starting eCT administration, but reappeared 7 days after completing the administration. Values presented as mean ± SEM. median eminence, area postrema, and lamina terminals. 29 It is possible that calcitonin exerts its analgesic actions through interactions with the central nervous system.
The hyperexcitation of the DRG is an important element in the occurrence of hyperalgesia. 7, 30, 31 The excessive excitability of the DRG is transmitted to secondary afferent neurons at the spinal dorsal horn, which may induce central sensitization. As for voltage-dependent sodium channels expressed in the DRG, seven subtypes have been cloned. In this study, no significant differences were observed in 
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Terashima et al mRNA-expression levels of Na V 1.6 among the three groups.
On the other hand, mRNA-expression levels of Na V 1.3, Na V 1.8, and Na V 1.9 increased in rats with radicular pain. Na V 1.8 and Na V 1.9, which are TTX-resistant sodium channels, are specifically expressed in small nociceptive neurons and believed to have important roles in the propagation of nociceptive information and expression of pathological pain. 32, 33 Furthermore, the expression of Na V 1.3, which is a TTX-sensitive sodium channel, may be induced by nerve damage to generate abnormal action potentials. 34 In the present study, in rats with radicular pain, the mRNAexpression levels of these voltage-dependent sodium channels increased. Watanabe et al 35 reported the expression of Na V 1.8 and Na V 1.9 in the DRG increased by herniated nucleus pulposus following disk puncture. We assumed that radicular pain symptoms, observed in patients with lumbar spinal canal stenosis or lumbar disk herniation, are caused by changes in sodium-channel expression and abnormal sodium currents occurring in nociceptive neurons. Further analysis of the participation of each Na V subunit in voltage-activated Figure 2 Changes in mRNA-expression levels of voltage-dependent TTX-sensitive and TTX-resistant sodium channels in the dorsal root ganglion. Notes: Sodium-channel mRNA-expression levels were normalized to those of GAPDH and then compared among the RP + eCT, RP + vehicle, and sham + vehicle groups using relative values to the mean value of the sham group. (A) mRNA-expression levels of Na V 1.3, values for the sham + vehicle and RP + vehicle groups were 0.82±0.04 and 1.19±0.09, respectively; therefore, expression increased significantly in the latter group (P<0.05). In the RP + eCT group, the expression level was 0.98±0.04, indicating that expression levels of Na V 1.3 improved to the same level as those of the sham group. (B) No significant differences were observed in expression levels of Na V 1.6 among the sham + vehicle (0.62±0.03), RP + vehicle (0.71±0.06), or RP + eCT (0.59±0.04) groups. (C and D) mRNA-expression levels of Na V 1.8 and Na V 1.9 were 0.92±0.07 and 0.92±0.08 in the sham + vehicle group and 1.37±0.10 and 1.26±0.10 in the RP + vehicle group, respectively; therefore, levels increased significantly in the latter group (P<0.05). Furthermore, levels were 0.94±0.05 and 0.99±0.06 in the RP + eCT group, respectively, indicating that mRNA-expression levels of Na V 1.8 and Na V 1.9 improved to the same level as those in the sham group. Values presented as mean ± SEM. *P<0.05 compared RP + vehicle. Abbreviations: eCT, elcatonin; RP, radicular pain; TTX, tetrodotoxin. 
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Calcitonin for radicular pain sodium currents may lead to enhanced understanding of the alleviation of analgesic effects on radicular pain. In the present study, after repeated calcitonin administration, mRNA-expression levels of these sodium channels improved to the same levels as those in the sham group, which suggested that calcitonin's action on the DRG may have played a role in normalizing the mechanism of pain transmission, particularly centered on C fibers. Ito et al 21 reported that transcription of Na V 1.3 increased and transcription of Na V 1.8 and Na V 1.9 decreased on the DRG in CCI rats. Further, they found that subcutaneous administration of eCT (15 U/kg/day) five times a week, from 11 to 27 days postsurgery, significantly restored the CCI-induced changes in the mRNA-expression levels of Na V 1.3, Na V 1.8, and Na V 1.9. Moreover, repeated administration of calcitonin normalized the gene expression of sodium channels in CCI rats.
The target site of calcitonin's direct action remains to be identified. Mystakidou et al 36 reported that calcitonin induces the secretion of blood β-endorphins, which has an analgesic effect. The serotonergic system is known to be involved in this analgesic effect. 37, 38 Ito et al 39 reported that calcitonin interacts with serotonin receptors on C-fiber termini to increase the number of serotonin receptors in the substantia gelatinosa of the dorsal horn in ovariectomized rats. They suggested that after nerve injury, it is important to reestablish the number of serotonin receptors so that the serotonin neurons that extend from the brain stem to the superficial dorsal horn can exert their pain-reducing action and provide hyperalgesia relief.
With regard to the expression of voltage-dependent sodium channels in the DRG, calcitonin can be presumed to act directly on the DRG or via calcitonin receptors or neurotrophic factors, such as the nerve growth factor or the glial cell line-derived neurotrophic factor. Further studies will be necessary to determine the site of the analgesic action of calcitonin, the pathway for intracellular transmission of information, and the mechanism of analgesic action of calcitonin in radicular pain.
Conclusion
Calcitonin has been used clinically as an analgesic agent for various pain-inducing diseases. The present preclinical study demonstrated that eCT was effective in male rats with radicular pain. In future, it is necessary to elucidate the true utility of calcitonin via clinical studies. Although calcitonin has known side effects, such as rash, facial flush, nausea, and vomiting, no serious side effects have been reported thus far. Therefore, calcitonin may be a preferred therapeutic option for elderly patients or those requiring long-term treatment.
Preclinical and clinical studies should be continued to clarify the mechanism of action of calcitonin in analgesia, identify diseases that have a favorable response to it, and specify the dose and period of administration for effective treatment.
